-
Case Report
-
J Mult Scler Neuroimmunol. 2021;12(2):35-38. Published online December 1, 2021.
- 시신경척수염 환자에서 리툭시맙 반복 투여 후 발생한 지연성 B형 간염의 재활성화
-
이혜선, 성의현, 성원재, 김승현
-
한양대학교 의과대학 신경과학교실
-
- Delayed Hepatitis B Reactivation after Repeated Rituximab Treatments for Neuromyelitis Optica Spectrum Disorder
-
Hyesun Lee, Euihyun Sung, Wonjae Sung, Seung Hyun Kim
-
Department of Neurology, Hanyang University College of Medicine, Seoul, Korea
-
- Abstract
- "Rituximab is a chimeric mouse human anti-CD20 monoclonal antibody that can reduce B cell numbers and antibody levels and has been prescribed for refractory neuromyelitis optica spectrum disorder (NMOSD). We report a case of delayed hepatitis B reactivation after repeated rituximab treatments with antibodies against aquaporin-4 in a seropositive NMOSD patient with chronic hepatitis B infection. Journal of Multiple Sclerosis and Neuroimmunology 12(2):35-38, 2021"
Keywords :Neuromyelitis optica; Hepatitis B; Rituximab
